167 related articles for article (PubMed ID: 38115002)
21. Vaccines for preventing malaria.
Graves P; Gelband H
Cochrane Database Syst Rev; 2003; (1):CD000129. PubMed ID: 12535387
[TBL] [Abstract][Full Text] [Related]
22. Single dose primaquine for clearance of Plasmodium falciparum gametocytes in children with uncomplicated malaria in Uganda: a randomised, controlled, double-blind, dose-ranging trial.
Eziefula AC; Bousema T; Yeung S; Kamya M; Owaraganise A; Gabagaya G; Bradley J; Grignard L; Lanke KH; Wanzira H; Mpimbaza A; Nsobya S; White NJ; Webb EL; Staedke SG; Drakeley C
Lancet Infect Dis; 2014 Feb; 14(2):130-9. PubMed ID: 24239324
[TBL] [Abstract][Full Text] [Related]
23. Efficacy and safety of the RTS,S/AS01 malaria vaccine during 18 months after vaccination: a phase 3 randomized, controlled trial in children and young infants at 11 African sites.
RTS,S Clinical Trials Partnership
PLoS Med; 2014 Jul; 11(7):e1001685. PubMed ID: 25072396
[TBL] [Abstract][Full Text] [Related]
24. Primaquine at alternative dosing schedules for preventing relapse in people with Plasmodium vivax malaria.
Milligan R; Daher A; Graves PM
Cochrane Database Syst Rev; 2019 Jul; 7(7):CD012656. PubMed ID: 31274189
[TBL] [Abstract][Full Text] [Related]
25. Seasonal malaria vaccination: protocol of a phase 3 trial of seasonal vaccination with the RTS,S/AS01
Chandramohan D; Dicko A; Zongo I; Sagara I; Cairns M; Kuepfer I; Diarra M; Tapily A; Issiaka D; Sanogo K; Mahamar A; Sompougdou F; Yerbanga S; Thera I; Milligan P; Tinto H; Ofori-Anyinam O; Ouedraogo JB; Greenwood B
BMJ Open; 2020 Sep; 10(9):e035433. PubMed ID: 32933955
[TBL] [Abstract][Full Text] [Related]
26. Triple therapy with artemether-lumefantrine plus amodiaquine versus artemether-lumefantrine alone for artemisinin-resistant, uncomplicated falciparum malaria: an open-label, randomised, multicentre trial.
Peto TJ; Tripura R; Callery JJ; Lek D; Nghia HDT; Nguon C; Thuong NTH; van der Pluijm RW; Dung NTP; Sokha M; Van Luong V; Long LT; Sovann Y; Duanguppama J; Waithira N; Hoglund RM; Chotsiri P; Chau NH; Ruecker A; Amaratunga C; Dhorda M; Miotto O; Maude RJ; Rekol H; Chotivanich K; Tarning J; von Seidlein L; Imwong M; Mukaka M; Day NPJ; Hien TT; White NJ; Dondorp AM
Lancet Infect Dis; 2022 Jun; 22(6):867-878. PubMed ID: 35276064
[TBL] [Abstract][Full Text] [Related]
27. Prevalence of and Risk Factors Associated with Polymerase Chain Reaction-Determined
Mwaiswelo R; Ngasala B; Jovel I; Xu W; Larsson E; Malmberg M; Gil JP; Premji Z; Mmbando BP; Mårtensson A
Am J Trop Med Hyg; 2019 May; 100(5):1179-1186. PubMed ID: 30860013
[TBL] [Abstract][Full Text] [Related]
28. Safety of a single low-dose of primaquine in addition to standard artemether-lumefantrine regimen for treatment of acute uncomplicated Plasmodium falciparum malaria in Tanzania.
Mwaiswelo R; Ngasala BE; Jovel I; Gosling R; Premji Z; Poirot E; Mmbando BP; Björkman A; Mårtensson A
Malar J; 2016 Jun; 15():316. PubMed ID: 27287612
[TBL] [Abstract][Full Text] [Related]
29. Primaquine or other 8-aminoquinoline for reducing Plasmodium falciparum transmission.
Graves PM; Gelband H; Garner P
Cochrane Database Syst Rev; 2015 Feb; (2):CD008152. PubMed ID: 25693791
[TBL] [Abstract][Full Text] [Related]
30. Duration of vaccine efficacy against malaria: 5th year of follow-up in children vaccinated with RTS,S/AS02 in Mozambique.
Campo JJ; Sacarlal J; Aponte JJ; Aide P; Nhabomba AJ; Dobaño C; Alonso PL
Vaccine; 2014 Apr; 32(19):2209-16. PubMed ID: 24631081
[TBL] [Abstract][Full Text] [Related]
31. Efficacy and safety of RTS,S/AS01 malaria vaccine with or without a booster dose in infants and children in Africa: final results of a phase 3, individually randomised, controlled trial.
RTS,S Clinical Trials Partnership
Lancet; 2015 Jul; 386(9988):31-45. PubMed ID: 25913272
[TBL] [Abstract][Full Text] [Related]
32. Clinical efficacy of chloroquine versus artemether-lumefantrine for Plasmodium vivax treatment in Thailand.
Krudsood S; Tangpukdee N; Muangnoicharoen S; Thanachartwet V; Luplertlop N; Srivilairit S; Wilairatana P; Kano S; Ringwald P; Looareesuwan S
Korean J Parasitol; 2007 Jun; 45(2):111-4. PubMed ID: 17570973
[TBL] [Abstract][Full Text] [Related]
33. Combining antimalarial drugs and vaccine for malaria elimination campaigns: a randomized safety and immunogenicity trial of RTS,S/AS01 administered with dihydroartemisinin, piperaquine, and primaquine in healthy Thai adult volunteers.
von Seidlein L; Hanboonkunupakarn B; Jittamala P; Pongsuwan P; Chotivanich K; Tarning J; Hoglund RM; Winterberg M; Mukaka M; Peerawaranun P; Sirithiranont P; Doran Z; Ockenhouse CF; Ivinson K; Lee C; Birkett AJ; Kaslow DC; Singhasivanon P; Day NPJ; Dondorp AM; White NJ; Pukrittayakamee S
Hum Vaccin Immunother; 2020; 16(1):33-41. PubMed ID: 31306084
[No Abstract] [Full Text] [Related]
34. Artemisinin-naphthoquine versus artemether-lumefantrine for uncomplicated malaria in Papua New Guinean children: an open-label randomized trial.
Laman M; Moore BR; Benjamin JM; Yadi G; Bona C; Warrel J; Kattenberg JH; Koleala T; Manning L; Kasian B; Robinson LJ; Sambale N; Lorry L; Karl S; Davis WA; Rosanas-Urgell A; Mueller I; Siba PM; Betuela I; Davis TM
PLoS Med; 2014 Dec; 11(12):e1001773. PubMed ID: 25549086
[TBL] [Abstract][Full Text] [Related]
35. Primaquine for preventing relapse in people with Plasmodium vivax malaria treated with chloroquine.
Galappaththy GN; Tharyan P; Kirubakaran R
Cochrane Database Syst Rev; 2013 Oct; 2013(10):CD004389. PubMed ID: 24163057
[TBL] [Abstract][Full Text] [Related]
36. Primaquine or other 8-aminoquinoline for reducing P. falciparum transmission.
Graves PM; Gelband H; Garner P
Cochrane Database Syst Rev; 2014 Jun; (6):CD008152. PubMed ID: 24979199
[TBL] [Abstract][Full Text] [Related]
37. Artesunate-amodiaquine and artemether-lumefantrine for the treatment of uncomplicated falciparum malaria in Liberia: in vivo efficacy and frequency of molecular markers.
Koko VS; Warsame M; Vonhm B; Jeuronlon MK; Menard D; Ma L; Taweh F; Tehmeh L; Nyansaiye P; Pratt OJ; Parwon S; Kamara P; Asinya M; Kollie A; Ringwald P
Malar J; 2022 Apr; 21(1):134. PubMed ID: 35477399
[TBL] [Abstract][Full Text] [Related]
38. Duration of protection with RTS,S/AS02A malaria vaccine in prevention of Plasmodium falciparum disease in Mozambican children: single-blind extended follow-up of a randomised controlled trial.
Alonso PL; Sacarlal J; Aponte JJ; Leach A; Macete E; Aide P; Sigauque B; Milman J; Mandomando I; Bassat Q; Guinovart C; Espasa M; Corachan S; Lievens M; Navia MM; Dubois MC; Menendez C; Dubovsky F; Cohen J; Thompson R; Ballou WR
Lancet; 2005 Dec; 366(9502):2012-8. PubMed ID: 16338450
[TBL] [Abstract][Full Text] [Related]
39. Seasonal vaccination with RTS,S/AS01
Dicko A; Ouedraogo JB; Zongo I; Sagara I; Cairns M; Yerbanga RS; Issiaka D; Zoungrana C; Sidibe Y; Tapily A; Nikièma F; Sompougdou F; Sanogo K; Kaya M; Yalcouye H; Dicko OM; Diarra M; Diarra K; Thera I; Haro A; Sienou AA; Traore S; Mahamar A; Dolo A; Kuepfer I; Snell P; Grant J; Webster J; Milligan P; Lee C; Ockenhouse C; Ofori-Anyinam O; Tinto H; Djimde A; Chandramohan D; Greenwood B
Lancet Infect Dis; 2024 Jan; 24(1):75-86. PubMed ID: 37625434
[TBL] [Abstract][Full Text] [Related]
40. Primaquine for preventing relapses in people with Plasmodium vivax malaria.
Galappaththy GN; Omari AA; Tharyan P
Cochrane Database Syst Rev; 2007 Jan; (1):CD004389. PubMed ID: 17253504
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
